Add BrightSurf on Google Email

Center for Genomic Regulation


It takes two to TANGO: New strategy to tackle fibrosis and scarring

Researchers developed a new experimental strategy to tackle scarring and fibrosis by releasing enough collagen to prevent tissue damage while protecting it from excessive amounts. The strategy, which uses molecules known as peptides to block the export of collagen from cells, shows promise in treating conditions such as scleroderma.

SourceCenter for Genomic Regulation·JournalNature Communications·TypeExperimental study·DateApr 24, 2024

Differentiation landscape of acute myeloid leukemia charted with new tool

A new method, CloneTracer, distinguishes between cancerous and healthy stem cells in acute myeloid leukemia (AML). The study reveals two distinct stem cell compartments and shows that progenitor cells respond better to therapy. This finding paves the way for developing new techniques to predict patient response to chemotherapy.

SourceCenter for Genomic Regulation·JournalCell Stem Cell·TypeExperimental study·DateApr 24, 2023

Researchers capture how genes fold and work at unprecedented resolution

A new genome imaging technique captures the structure of the human genome at unprecedented resolution, revealing how individual genes fold and work. This technique, called Modeling immuno-OligoSTORM (MiOS), combines high-resolution microscopy and advanced computational modeling to provide a detailed picture of gene shape and function.

SourceCenter for Genomic Regulation·JournalNature Structural & Molecular Biology·TypeExperimental study·DateOct 13, 2022

Human eggs remain healthy for decades by putting ‘batteries on standby mode’

Researchers discovered that human egg cells skip a crucial metabolic reaction to maintain their reproductive capacity without losing energy, allowing them to remain dormant in ovaries for up to 50 years. This finding explains why some women with mitochondrial conditions linked to this reaction do not experience reduced fertility.

SourceCenter for Genomic Regulation·JournalNature·TypeExperimental study·DateJul 20, 2022

Common antiretroviral drug improves cognition in mouse model of Down syndrome

Researchers found that lamivudine improved cognition in a mouse model of Down syndrome, which could lead to new pharmacological treatments for cognitive impairment. The study highlights the potential of targeting retrotransposons, segments of DNA that contribute to neurodegenerative diseases.

SourceCenter for Genomic Regulation·JournalJournal of Cellular and Molecular Medicine·TypeExperimental study·DateJun 28, 2022

Act of sabotage determines mammalian embryonic development

Researchers found that human embryos express a vast variety of alternative mRNAs when they are just 8 cells old, leading to a temporary collapse of splicing regulation at the zygotic genome activation stage. This phenomenon is developmentally programmed and occurs because it is necessary for functional reasons, ultimately affecting DNA...

SourceCenter for Genomic Regulation·JournalScience Advances·TypeExperimental study·DateApr 13, 2022

Unprecedented data sharing driving new rare disease diagnoses in Europe

A collaborative effort has led to the diagnosis of 255 new rare disease cases in Europe through unprecedented data sharing. The Solve-RD project utilizes a genomic and phenotypic analysis platform to reanalyze data from 8,393 individuals, identifying previously unknown genetic variants that can tailor treatment for affected patients.

SourceCenter for Genomic Regulation·JournalEuropean Journal of Human Genetics·DateJun 1, 2021